- Home
- AGIO vs DFH Comparison
AGIO vs DFH Comparison
Compare AGIO & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- DFH
- Stock Information
- Founded
- AGIO 2007
- DFH 2008
- Country
- AGIO United States
- DFH United States
- Employees
- AGIO N/A
- DFH N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- DFH Homebuilding
- Sector
- AGIO Health Care
- DFH Consumer Discretionary
- Exchange
- AGIO Nasdaq
- DFH Nasdaq
- Market Cap
- AGIO 2.0B
- DFH 2.0B
- IPO Year
- AGIO 2013
- DFH 2021
- Fundamental
- Price
- AGIO $35.22
- DFH $21.30
- Analyst Decision
- AGIO Buy
- DFH Hold
- Analyst Count
- AGIO 7
- DFH 1
- Target Price
- AGIO $56.33
- DFH $32.00
- AVG Volume (30 Days)
- AGIO 621.1K
- DFH 364.8K
- Earning Date
- AGIO 02-13-2025
- DFH 02-27-2025
- Dividend Yield
- AGIO N/A
- DFH N/A
- EPS Growth
- AGIO N/A
- DFH 15.80
- EPS
- AGIO 11.64
- DFH 3.03
- Revenue
- AGIO $36,498,000.00
- DFH $4,028,851,000.00
- Revenue This Year
- AGIO $166.22
- DFH $15.56
- Revenue Next Year
- AGIO $98.36
- DFH N/A
- P/E Ratio
- AGIO $3.03
- DFH $6.94
- Revenue Growth
- AGIO 36.07
- DFH 8.59
- 52 Week Low
- AGIO $27.14
- DFH $20.54
- 52 Week High
- AGIO $62.58
- DFH $44.38
- Technical
- Relative Strength Index (RSI)
- AGIO 54.02
- DFH 38.94
- Support Level
- AGIO $33.25
- DFH $21.28
- Resistance Level
- AGIO $34.86
- DFH $23.00
- Average True Range (ATR)
- AGIO 1.33
- DFH 0.96
- MACD
- AGIO 0.37
- DFH 0.06
- Stochastic Oscillator
- AGIO 97.99
- DFH 30.52
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.